Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient’s immune cells to fight cancer.
SimplyTest has launched SimplyTest Oral Health-IMPLANT, a new molecular assay designed to detect microbial species linked to peri-implant disease and implant failure. The test is the latest addition to the company’s growing SimplyTest Oral Health line, which also includes SimplyTest Oral Health-PERIO and others.
ALISO VIEJO, Calif., July 23, 2025 /PRNewswire/ — In a major milestone for chronic post-amputation pain treatment, the first commercial patient in the U.S. has been successfully implanted with the FDA-approved Altius® System – marking the beginning of the company’s mission to relieve pain and restore life for lower limb amputees.
New AI-Enabled Technology Aims to Personalize Fluid Management and Improve Outcomes Across Hospital Network
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets
Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine.
https://www.discovermagazine.com/health/how-a-chatty-ancient-protein-in-our-gut-could-be-giving-us-a-sixth-sense
Philips (NYSE: PHG)+ announced today that it received FDA 510(k) clearance for the latest UroNav image-guided navigation system.
Elekta announced today that it received FDA 510(k) clearance to expand indications for its Leksell Gamma Knife radiosurgery system.
Imperative Care announced today that it received FDA 510(k) clearance for its novel Zoom 7X catheter for aspiration thrombectomy procedures.